Increase in early detection of drug toxicity to minimize financial losses has resulted boost to the Organ-on-chip market; according to a research conducted by Kenneth Research

The organ-on-chip market is expected to grow with an annual rate of almost 40% for the next 10 to 15 years. The device is very much in demand nowadays as the tendency and possibility to control things has increased with time. And this demand will boost the market globally.

The organ chip market is expected to exceed 10 million U.S. dollars in 2021, and it is expected to reach 170 million U.S. dollars in 2023, with a compound annual growth rate of over 40% from 2022 to 2030. OOC) is a microfluidic cell culture device that was developed using a microchip manufacturing method that contains continuously perfused chambers that are inhabited by living cells and are used to simulate physiological functions at the organ and tissue level. The chip develops a narrow channel for blood and air flow in the lungs, intestines, liver, heart and other organs. Such equipment produces multi-level tissue and organ functions, which is not feasible for traditional 2D and 3D culture systems. Organ chips provide a wide range of applications, such as disease modelling, patient stratification, and phenotypic screening.

Major market players:

Mimetas (Netherlands), Emulate (US), InSphero (Switzerland), Ascendance Bio (US), CN Bio (UK), TissUse (Germany), Kirkstall (UK), HUREL (HUREL) (US), SynVivo (US), AxoSim (US), and Nortis (US).

The global chip market is segmented by type and geographic location. According to different types, the market is divided into crispy heart, crispy intestine, crispy kidney, crispy liver, and crispy lung. Geographically, we analyzed the chip component market in North America, Europe, Asia Pacific and Rummy. The world market for heart-shaped chips continues to grow. Lung on Chip maintained its long-term global chip market share in 2016 and is expected to dominate during the forecast period. In 2016, North America had the largest market share due to advanced technological innovation and growing medical applications. Due to favorable opportunities provided by countries such as China, India and Japan, the Asia-Pacific region is expected to achieve the highest growth rate during the forecast period.

The growing demand for chip-based long-term healthcare equipment is expected to drive global market growth. The organ system on the chip can be used for real-time imaging of living cells in functional tissues, laboratory biochemical analysis, genetic and metabolic activities, and can greatly increase uptake. Drug testing is an inexpensive way to quickly evaluate samples. Scientists and researchers use organ chip implants to control the effects of drugs in the body. In addition, with the help of this technology, the toxicity or efficacy of the drug has been identified in different parts of the body, thus driving the growth of the market. Therefore, the demand for the development of second-hand laboratory equipment is expected to increase to supplement the market growth. Solid regenerative organs can perform certain organic functions in a short time, indicating the potential of solid regenerative organs in clinical applications in the future.

This study provides an analytical overview of the long-term global market share, current trends and forecasts of microarrays to reflect the scale of future investment. The overall ability of the market to understand profit trends determines the gaining of a strong position. This report is a detailed impact analysis of Porters’ 2016 analysis and provides a quantitative analysis of the current market by 2023. Information about key drivers, constraints and opportunities. The influence of buyers and suppliers among the top five market forces is reflected in chip manufacturing.

Main market regions:

The study on Organ-on-chips market was global in nature and conducted in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa). In addition, areas like Market size, Y-O-Y growth & Opportunity Analysis, market players competitive study, investment opportunities, demand for future outlook etc. have been covered and displayed in the Global Organs-on-chip market research report to ensure it dives deep to achieve strategic competitive intelligence in the segment.

Related posts

Leave a Comment